Go Pro
→ Where to Put $100 Before Trump's New Tech Law Rolls Out (From Brownstone Research) (Ad)tc pixel
NASDAQ:OSRH

OSR Q2 2025 Earnings Report

OSR logo
$0.36 +0.01 (+1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$0.36 +0.00 (+0.25%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

OSR EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OSR Revenue Results

Actual Revenue
$1.14 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OSR Announcement Details

Quarter
Q2 2025
Date
8/14/2025
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

OSR Earnings Headlines

OSR Health Earnings Estimates, EPS & Revenue | NASDAQ:OSRH
July 6, 2026  |  benzinga.comhttps://www.benzinga.com/quote/OSRH/earnings
Analyzing OSR (NASDAQ:OSRH) and Marblegate Acquisition (NASDAQ:GATE)
July 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30879959
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in modern history - larger than Paul Tudor Jones' Black Monday bet and Michael Burry's $700 million Big Short. While most investors chase AI stocks, insiders including Ray Dalio and Tudor Jones have quietly repositioned. The last comparable shock sent certain stocks up 2,464%, 2,778%, and even 13,000% - turning a $10,000 stake into over $1.3 million. Dr. Eifrig has identified one stock at the center of this story and released a free broadcast to help investors act before the window closes.tc pixel
July 14 at 1:00 AM  |  Stansberry Research (Ad)
CORRECTION FROM SOURCE: Emerging Growth Research Issues Flash Report on OSR Health, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target
July 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/correction-source-emerging-growth-research-170500642.html
OSR Holdings Rebrands as OSR Health in Name Change
June 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/osr-holdings-rebrands-as-osr-health-in-name-change?utm_source=marketbeat.com&utm_medium=referral
OSR Holdings Secures VXM01 Rights in Asset Deal
June 2, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/osr-holdings-secures-vxm01-rights-in-asset-deal?utm_source=marketbeat.com&utm_medium=referral
See More OSR Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OSR? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OSR and other key companies, straight to your email.

About OSR

OSR (NASDAQ:OSRH) Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

View OSR Profile
Earnings Tools